January 2024 – PRESS RELEASE – January 8, 2024. Conshohocken, PA – Celéri Health is pleased to announce its collaboration with Guam Regional Medical City on a first-of-its-kind pain safety net program. Guam Regional Medical City treats a large population of
December 2023 – PRESS RELEASE – December 1, 2023. Conshohocken, PA – Celéri Health’s Research Group is pleased to announce its collaboration with Averitas Pharma on a post-market observational multi-center study. Neuropathy is one of the most common long-term complications of
October 2023 – PRESS RELEASE – October 24, 2023, Conshohocken, PA – Celéri Health’s technology innovation team, Celéri Labs, is pleased to announce its collaboration with Google to leverage their Firebase and Google Cloud Platform Services such as BigQuery and Cloud
August 2023 – PRESS RELEASE – August 17, 2023, Conshohocken, PA – Celéri Health is pleased to announce its collaboration with CornerLoc™ and its pending multi-center SPARTAN Study. Celéri Health will leverage its platform product, PainExplorer™ powered by SMART-TRIAL, for the
May 2023 – MedTech Strategist – Digital Issue Pain is individual, yet the field lacks biomarkers by which clinicians can tailor therapies to their patients. To enable more effective treatments, Celéri Health brings real-world data and an AI-enabled platform to clinicians and therapy
FOR IMMEDIATE RELEASE Conshohocken, PA, August 22, 2022 – Celéri Health, LLC (“Celéri”), Celéri Health, LLC (“Celéri”), the leading provider of pain-centric technology, has announced the offering of their database for pain researcher and stakeholder collaboration – called the PainRWD™ Science Cloud.
FOR IMMEDIATE RELEASE Conshohocken, PA, April 27, 2022 – Celéri Health, LLC (“Celéri”), Celéri Health is pleased to announce its partnership with the University of Wisconsin–Madison Center for Health Disparities Research, through which their Neighborhood Atlas® Area Deprivation Index (ADI) will be
Article originally published on Cision. With the support of pain experts and industry leaders, Interaxon explores the therapeutic efficacy of its Muse® mEEG Biofeedback and new Transforming Pain eCourse for pain management TORONTO, July 20, 2021 /PRNewswire/ — Interaxon, along with Celéri Health and pain
This article originally posted by Technical.ly. Celéri Health, a Wilmington-based medtech company, aims to revolutionize pain measurement by developing a platform that goes beyond the traditional zero-to-10 rating scale. Led by Dr. Michael Fishman and Dr. Jason Pope, Celéri Health’s
